Q&A

Beyond CDMO To Trusted Partner: An Interview With Peter Khoury, President And CEO, Ology Bioservices

Source: Ology Bioservices
Final approved by Resilience_inset article image_300dpi_30Apr2021-sized

(Note: in April 2021, Ology Bioservices® (Ology Bio) was acquired by National Resilience, Inc. (Resilience). Peter Khoury is transitioning to a consulting role as Ology Bio continues its work and expands the business.)

Ology Bioservices® (Ology Bio) is a US-based biopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing CGMP (and non-GMP) high quality services to our clients for the development and production of cell and gene therapies, viral vectors, oncolytic viruses and vaccines against infectious diseases and cancer. Peter Khoury, Former President and CEO of Ology Bio, gives insight into growing the company, the biotech CMO industry, and what’s next for Ology Bio.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Ology Bioservices